These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6893845)

  • 1. [The effect of intrathecal amikacin in the treatment of postoperative meningitis (author's transl)].
    Takagi K; Fukushima T
    Jpn J Antibiot; 1980 Jun; 33(6):664-7. PubMed ID: 6893845
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intrathecal administration of amikacin in postoperative refractory meningitis].
    Yamashima T; Shoin K; Someya S; Kogure Y; Kubota T; Yamamoto S
    Jpn J Antibiot; 1983 Mar; 36(3):522-8. PubMed ID: 6688276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Klebsiella meningitis treated with intrathecal amikacin.
    Block CS; Cassel R; Koornhof HJ; Robinson RG; Lewer-Allen CM
    Lancet; 1977 Jun; 1(8026):1371-2. PubMed ID: 69095
    [No Abstract]   [Full Text] [Related]  

  • 4. Intrathecal amikacin administration. Use in the treatment of gentamicin-resistant Klebsiella pneumoniae meningitis.
    Hamory B; Ignatiadis P; Sande MA
    JAMA; 1976 Oct; 236(17):1973-4. PubMed ID: 787564
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intraventricular amikacin in the treatment of meningoventriculitis caused by Gram-negative organisms].
    Ludeña Carpio C; Madero López L; Barrio Corrales F; Lozano Jiménez C; Martínez Beltrán J; Loza E
    An Esp Pediatr; 1981 Nov; 15(5):503-6. PubMed ID: 7036809
    [No Abstract]   [Full Text] [Related]  

  • 6. [CSF levels of amikacin following systemic application in patients with slightly and severely impaired blood cerebrospinal barrier (author's transl)].
    Brückner O; Collmann H; Hoffmann HG
    Immun Infekt; 1982 Mar; 10(2):76-81. PubMed ID: 7068169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cerebrospinal fluid leaks and gram-negative bacillary meningitis with large doses of intrathecal amikacin and systemic antibiotics.
    Gilbert VE; Beals JD; Natelson SE; Tyler WA
    Neurosurgery; 1986 Apr; 18(4):402-6. PubMed ID: 3754626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience of amikacin intravenous drip infusion (author's transl)].
    Tsuchiya J; Miyao S; Shinonome S; Takakuwa M; Mou M
    Jpn J Antibiot; 1980 Jul; 33(7):711-5. PubMed ID: 6935444
    [No Abstract]   [Full Text] [Related]  

  • 9. Intraventricular administration of amikacin for complicated Gram-negative meningitis and ventriculitis.
    Wirt TC; McGee ZA; Oldfield EH; Meacham WF
    J Neurosurg; 1979 Jan; 50(1):95-9. PubMed ID: 363982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenous administration of amikacin sulfate for the infections complicated with hematologic disorders (author's transl)].
    Ueda T; Takubo T; Hasegawa Y; Shibata H; Nakamura H; Masaoka T; Yoshitake J
    Jpn J Antibiot; 1977 Dec; 30(12):1021-5. PubMed ID: 271749
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical results with amikacin (BB-K8) in respiratory infections (author's transl)].
    Ito T
    Jpn J Antibiot; 1976 Aug; 29(8):731-4. PubMed ID: 957522
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of absorption and excretion of powdery preparation for injection and liquid preparation of BB-K8 (amikacin) (author's transl)].
    Okubo H; Okamoto Y; Uba F; Ueda Y; Ueda T
    Jpn J Antibiot; 1975 Jun; 28(3):283-7. PubMed ID: 1152282
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic experience of Proteus morganii septicemia with amikacin (author's transl)].
    Tomioka H; Kobayashi Y; Shigeta Y
    Jpn J Antibiot; 1977 Aug; 30(8):593-5. PubMed ID: 909148
    [No Abstract]   [Full Text] [Related]  

  • 14. [Amikacin therapy for serious infections in hematopoietic disorders (author's transl)].
    Fujii H; Shimizu T
    Jpn J Antibiot; 1981 Jun; 34(6):841-51. PubMed ID: 7289039
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic effect of amikacin for infections with gram-negative bacilli, especially for stubborn respiratory infections (author's transl)].
    Oizumi K; Watanabe A; Konno K; Hayashi I; Kawamorida K; Nagai K; Kudo S; Kurita K; Kaishio K
    Jpn J Antibiot; 1978 Jan; 31(1):15-23. PubMed ID: 633626
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of E. coli septicemia successfully treated with amikacin (author's transl)].
    Ueda Y; Matsumoto F; Saito A; Saigusa M
    Jpn J Antibiot; 1975 Oct; 28(5):655-6. PubMed ID: 1100873
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of Klebsiella pneumonia with complication of CO2-narcosis successfully treated with amikacin (author's transl)].
    Nakagami K; Yatani Y; Osakabe Y; Kunieda T; Suzuki H; Satomi T; Saruta E; Noguchi E
    Jpn J Antibiot; 1980 May; 33(5):641-4. PubMed ID: 7001088
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of amikacin intravenous therapy in pediatrics (author's transl)].
    Nakazawa S; Sato H; Fujii N; Kojima S; Narita A; Chikaoka H; Oka S
    Jpn J Antibiot; 1980 Oct; 33(10):1104-10. PubMed ID: 7206214
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of hospital-acquired urinary infections with amikacin (author's transl)].
    Weidner W; Nöske HD; Sziegoleit A; Schröder R; Leidenfrost U
    Med Klin; 1979 Jul; 74(27):1071-6. PubMed ID: 470792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative clinical effect of amikacin and gentamicin on complicated urinary tract infections by doubld-blind method (author's transl)].
    Nishiura T; Kawada Y; Ichikawa T; Nakano I; Tsuji I; Kumamoto Y; Shishido S
    Nihon Hinyokika Gakkai Zasshi; 1978 Mar; 69(3):381-98. PubMed ID: 351248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.